PATENT CLAIM ANALYSIS

Application Number: 15944659
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "094000"]

Abstract:
A novel class of drugs for treating androgen receptor (AR) positive cancer including prostate cancer and breast cancer are described. The drugs include the chemical scaffolds of a high affinity androgen receptor ligand and a histone deacetylase inhibitor. Also described are compositions including the novel drugs and methods of treating AR positive cancer using the compositions.

Claim (Index 18):
The method of  claim 17 , wherein the AR positive cancer is prostate cancer or breast cancer.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 91.0
- Lexical Diversity: 1.64865
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15417860', '15346743', '15331777', '15222734', '15457782']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.796356693280536
- 35 USC 102 Novelty (BERT): 0.5738228324252
- Combined Prediction Score: 0.7741033071950025
- Mean Citation Score: 350.17211000000015
- Max Citation Score: 511.5854
- Similarity Product: 358.4666928984165

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test